Press Releases

Press Releases

ImCheck Therapeutics Appoints Prof. René Hoet, PhD, as Chief Scientific Officer

|   Science & Medicine

ImCheck Therapeutics, an emerging biopharmaceutical company developing novel immune modulators against cancer and…

Read more

ImCheck Therapeutics appoints Dr. Debasish Roychowdhury as its independent Chairman of the Board

|   Leadership & Corporate

With over a decade of patient care as a hematologist/oncologist and a career as a big pharma senior executive in R&D,…

Read more

ImCheck Therapeutics obtains 1M€ from Bpifrance to contribute to the development of a novel therapeutic antibody in immuno-oncology

|   Financial & Business

First non-dilutive funding received by ImCheck following its initial fundraising of 20 M€ in May 2017

Read more

ImCheck Therapeutics raises €20 Million and appoints its CEO

|   Financial & Business

Emerging leader in immuno-oncology accelerates its development programs and prepares for entry into the clinic

Read more

STAY IN TOUCH WITH OUR LATEST NEWS

Subscribe to receive our press releases and related news